Replies to post #600300 on NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

ATLnsider,

Been thinking big and looking for big for about 25 years. I believed that the typical cycle for breakthrough discovery was about to hit and since 2012 I became more and more convinced it had. I determined long ago to find some company that was working on a broad spectrum approach to defeating cancer because there are just too many pathways for cancer to advance from for big success with single targets.
It’s fun watching folks start to see the big picture now and then come to find out how far along NWBO has come in the discovery and implementation process for BROAD SCALE APPLICATION. One day eyes will open wide and folks will say how could we have missed this. Well, we have all had lots of help missing the big picture from distractions, distortions and dishonesty. Not anymore!; ). Best wishes.

[hyperopia]

ATLnsider, I agree that Northwest Bio seems to state at every opportunity that DCVax is potentially applicable to other solid tumors, and there seems to be a lot of discussion around an “all-solid-tumors approval” lately. But I don’t think that necessarily means that they intend to apply for tissue-agnostic approval at this time. I believe the primary focus right now, is on applying for, and receiving marketing approval for ndGBM and rGBM. Then, once that is achieved, they will attempt to expand the label for other indications.